ArticlePharmaceuticals (Basel, Switzerland)2025

In Vivo PK-PD and Drug-Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia.

Guanqin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.